The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 3,994
SCHULMAN, S., ANGERÅS, U., BERGQVIST, D., ERIKSSON, B., LASSEN, M. R., & FISHER, W. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03678.x · Cited by 3,756
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Holcomb, J. B., Tilley, B. C., Baraniuk, S., Fox, E. E., Wade, C. E., Podbielski, J. M., del Junco, D. J., Brasel, K. J., Bulger, E. M., Callcut, R. A., et al. (2015) · JAMA · doi:10.1001/jama.2015.12 · Cited by 2,526
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
Villanueva, C., Colomo, A., Bosch, A., Concepción, M., Hernandez-Gea, V., Aracil, C., Graupera, I., Poca, M., Alvarez-Urturi, C., Gordillo, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211801 · Cited by 1,735
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380701 · Cited by 1,702
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.513 · Cited by 1,641
Self-citationPrevention of bleeding in patients with atrial fibrillation undergoing PCI
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., van Eickels, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611594 · Cited by 1,590
Self-citationIdarucizumab for Dabigatran Reversal
Pollack, C. V., Reilly, P. A., Eikelboom, J., Glund, S., Verhamme, P., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kamphuisen, P. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502000 · Cited by 1,552
Self-citationStangier, J., Haertter, S., Liesenfeld, K.-H., Wienen, W., Feuring, M., Clemens, A., & Ryn, J. V. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-11-0758 · Cited by 1,382
Eerenberg, E. S., Kamphuisen, P. W., Sijpkens, M. K., Meijers, J. C., Buller, H. R., & Levi, M. (2011) · Circulation · doi:10.1161/circulationaha.111.029017 · Cited by 1,361
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V., & Singer, D. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022913 · Cited by 1,277
Evidence-Based Management of Anticoagulant Therapy
Holbrook, A., Schulman, S., Witt, D. M., Vandvik, P. O., Fish, J., Kovacs, M. J., Svensson, P. J., Veenstra, D. L., Crowther, M., & Guyatt, G. H. (2012) · Chest · doi:10.1378/chest.11-2295 · Cited by 1,269
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Douketis, J. D., Spyropoulos, A. C., Kaatz, S., Becker, R. C., Caprini, J. A., Dunn, A. S., Garcia, D. A., Jacobson, A., Jaffer, A. K., Kong, D. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501035 · Cited by 1,184
Idarucizumab for dabigatran reversal
Garrett, A. D., PharmD, & Bcps (2015) · Cited by 1,167
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
Pollack, C. V., Reilly, P. A., van Ryn, J., Eikelboom, J. W., Glund, S., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kam, C.-W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707278 · Cited by 1,154
Self-citationColloids versus crystalloids for fluid resuscitation in critically ill patients
Perel, P., Roberts, I., & Ker, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000567.pub6 · Cited by 1,115
Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage
Carson, J. L., Guyatt, G., Heddle, N. M., Grossman, B. J., Cohn, C. S., Fung, M. K., Gernsheimer, T., Holcomb, J. B., Kaplan, L. J., Katz, L. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.9185 · Cited by 1,113
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
Siegal, D. M., Curnutte, J. T., Connolly, S. J., Lu, G., Conley, P. B., Wiens, B. L., Mathur, V. S., Castillo, J., Bronson, M. D., Leeds, J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510991 · Cited by 1,047 · cited 2×
“A bolus and 2-hour infusion of andexanet alfa rapidly reversed the anticoagulant effects of apixaban and rivaroxaban in older healthy volunteers (81).”
BackgroundSelf-citationSarode, R., Milling, T. J., Refaai, M. A., Mangione, A., Schneider, A., Durn, B. L., & Goldstein, J. N. (2013) · Circulation · doi:10.1161/circulationaha.113.002283 · Cited by 813
Self-citationAndexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
Connolly, S. J., Milling, T. J., Eikelboom, J. W., Gibson, C. M., Curnutte, J. T., Gold, A., Bronson, M. D., Lu, G., Conley, P. B., Verhamme, P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607887 · Cited by 807
Self-citationBaharoglu, M. I., Cordonnier, C., Salman, R. A.-S., de Gans, K., Koopman, M. M., Brand, A., Majoie, C. B., Beenen, L. F., Marquering, H. A., Vermeulen, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30392-0 · Cited by 766
Young, P., Bailey, M., Beasley, R., Henderson, S., Mackle, D., McArthur, C., McGuinness, S., Mehrtens, J., Myburgh, J., Psirides, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.12334 · Cited by 728
Stangier, J., Rathgen, K., Stähle, H., & Mazur, D. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318170-000000000-00000 · Cited by 722
Lu, G., DeGuzman, F. R., Hollenbach, S. J., Karbarz, M. J., Abe, K., Lee, G., Luan, P., Hutchaleelaha, A., Inagaki, M., Conley, P. B., et al. (2013) · Nature Medicine · doi:10.1038/nm.3102 · Cited by 701
National trends in ambulatory oral anticoagulant use
Barnes, G. D., Lucas, E., Alexander, G. C., & Goldberger, Z. D. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.05.044 · Cited by 598
Kuramatsu, J. B., Gerner, S. T., Schellinger, P. D., Glahn, J., Endres, M., Sobesky, J., Flechsenhar, J., Neugebauer, H., Jüttler, E., Grau, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.0846 · Cited by 568
Marlu, R., Hodaj, E., Paris, A., Albaladejo, P., Crackowski, J., & Pernod, G. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0179 · Cited by 501
Mismetti, P., Laporte, S., Pellerin, O., Ennezat, P.-V., Couturaud, F., Elias, A., Falvo, N., Meneveau, N., Quere, I., Roy, P.-M., et al. (2015) · JAMA · doi:10.1001/jama.2015.3780 · Cited by 489
Yao, X., Abraham, N. S., Alexander, G. C., Crown, W., Montori, V. M., Sangaralingham, L. R., Gersh, B. J., Shah, N. D., & Noseworthy, P. A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003074 · Cited by 452
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
Cuker, A., Siegal, D. M., Crowther, M. A., & Garcia, D. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.065 · Cited by 449
Self-citationDoherty, J. U., Gluckman, T. J., Hucker, W. J., Januzzi, J. L., Ortel, T. L., Saxonhouse, S. J., & Spinler, S. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.024 · Cited by 441
Self-citationKubitza, D., Becka, M., Mueck, W., Halabi, A., Maatouk, H., Klause, N., Lufft, V., Wand, D. D., Philipp, T., & Bruck, H. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03753.x · Cited by 432
Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban
Ansell, J. E., Bakhru, S. H., Laulicht, B. E., Steiner, S. S., Grosso, M., Brown, K., Dishy, V., Noveck, R. J., & Costin, J. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1411800 · Cited by 419
Levy, J. H., Ageno, W., Chan, N. C., Crowther, M., Verhamme, P., & Weitz, J. I. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13227 · Cited by 375
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants
Samuelson, B. T., Cuker, A., Siegal, D. M., Crowther, M., & Garcia, D. A. (2017) · Chest · doi:10.1016/j.chest.2016.08.1462 · Cited by 345
Self-citationZhou, W., Schwarting, S., Illanes, S., Liesz, A., Middelhoff, M., Zorn, M., Bendszus, M., Heiland, S., van Ryn, J., & Veltkamp, R. (2011) · Stroke · doi:10.1161/strokeaha.111.624650 · Cited by 324
Glund, S., Stangier, J., Schmohl, M., Gansser, D., Norris, S., van Ryn, J., Lang, B., Ramael, S., Moschetti, V., Gruenenfelder, F., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60732-2 · Cited by 319
Secular Trends in Occurrence of Acute Venous Thromboembolism: The Worcester VTE Study (1985-2009)
Huang, W., Goldberg, R. J., Anderson, F. A., Kiefe, C. I., & Spencer, F. A. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.03.041 · Cited by 297
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H.-C., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw058 · Cited by 269
Nielsen, P. B., Larsen, T. B., Skjøth, F., Gorst-Rasmussen, A., Rasmussen, L. H., & Lip, G. Y. H. (2015) · Circulation · doi:10.1161/circulationaha.115.015735 · Cited by 265
Evidence-based treatment recommendations for uremic bleeding
Hedges, S. J., Dehoney, S. B., Hooper, J. S., Amanzadeh, J., & Busti, A. J. (2007) · Nature Reviews Nephrology · doi:10.1038/ncpneph0421 · Cited by 263
Zahir, H., Brown, K. S., Vandell, A. G., Desai, M., Maa, J.-F., Dishy, V., Lomeli, B., Feussner, A., Feng, W., He, L., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013445 · Cited by 252
Restarting Anticoagulation and Outcomes After Major Gastrointestinal Bleeding in Atrial Fibrillation
Qureshi, W., Mittal, C., Patsias, I., Garikapati, K., Kuchipudi, A., Cheema, G., Elbatta, M., Alirhayim, Z., & Khalid, F. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.044 · Cited by 218
Murthy, S. B., Gupta, A., Merkler, A. E., Navi, B. B., Mandava, P., Iadecola, C., Sheth, K. N., Hanley, D. F., Ziai, W. C., & Kamel, H. (2017) · Stroke · doi:10.1161/strokeaha.116.016327 · Cited by 205
Levi, M., Moore, K. T., Castillejos, C. F., Kubitza, D., Berkowitz, S. D., Goldhaber, S. Z., Raghoebar, M., Patel, M. R., Weitz, J. I., & Levy, J. H. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12599 · Cited by 197
Chai-Adisaksopha, C., Hillis, C., Siegal, D. M., Movilla, R., Heddle, N., Crowther, M., & Iorio, A. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-04-0266 · Cited by 190
Self-citationPRAGST, I., ZEITLER, S. H., DOERR, B., KASPEREIT, F. J., HERZOG, E., DICKNEITE, G., & van RYN, J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04859.x · Cited by 186
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban
Chang, M., Yu, Z., Shenker, A., Wang, J., Pursley, J., Byon, W., Boyd, R. A., LaCreta, F., & Frost, C. E. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.633 · Cited by 171
Reilly, P. A., Bernstein, R. A., Dubiel, R., Eikelboom, J. W., Glund, S., Huisman, M. V., Hylek, E. M., Kam, C. W., Kamphuisen, P. W., Kreuzer, J., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0192 · Cited by 164
Self-citationSmilowitz, N. R., Oberweis, B. S., Nukala, S., Rosenberg, A., Zhao, S., Xu, J., Stuchin, S. A., Iorio, R. R., Errico, T. J., Radford, M. J., et al. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.10.012 · Cited by 153
Dzik, S., Blajchman, M. A., Fergusson, D. A., Hameed, M. S., Henry, B., Kirkpatrick, A. W., Korogyi, T., Logsetty, S., Skeate, R. C., Stanworth, S. J., et al. (2011) · Critical Care · doi:10.1186/cc10498 · Cited by 150
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban
Ansell, J., Bakhru, S., Laulicht, B., Steiner, S. S., GROSSO, M. A., Brown, K. D., Dishy, V., Lanz, H., Mercuri, M. F., Noveck, R. J., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-03-0224 · Cited by 149
Sengupta, N., Feuerstein, J. D., Patwardhan, V. R., Tapper, E. B., Ketwaroo, G. A., Thaker, A. M., & Leffler, D. A. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.398 · Cited by 136
Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis
Dias, C. S., Moore, K. T., Murphy, J., Ariyawansa, J., Smith, W. B., Mills, R. M., & Weir, M. R. (2016) · American Journal of Nephrology · doi:10.1159/000445328 · Cited by 133
Marbury, T. C., Matsushima, N., Chen, S., Wickremasingha, P. K., He, L., Dishy, V., Brown, K. S., & Parasrampuria, D. A. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-06-0547 · Cited by 128
Antidotes for Novel Oral Anticoagulants: Current Status and Future Potential
Crowther, M., & Crowther, M. A. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303402 · Cited by 120
Ruff, C. T., Giugliano, R. P., & Antman, E. M. (2016) · Circulation · doi:10.1161/circulationaha.116.021831 · Cited by 115
Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review
Cuker, A. C., & Husseinzadeh, H. D. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1185-7 · Cited by 111
Self-citationOral anticoagulant-associated intracerebral hemorrhage
Cervera, Á., Amaro, S., & Chamorro, Á. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6153-3 · Cited by 109
Nielsen, P. B., Larsen, T. B., Skjøth, F., & Lip, G. Y. H. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9369 · Cited by 104
Nishijima, D. K., Zehtabchi, S., Berrong, J., & Legome, E. L. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318256dfc5 · Cited by 102
Chai‐Adisaksopha, C., Hillis, C., Monréal, M., Witt, D. M., & Crowther, M. A. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-01-0063 · Cited by 98
Hawryluk, G. W. J., AUSTIN, J. W., Furlan, J. C., Lee, J. B., O'Kelly, C. J., & Fehlings, M. G. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03882.x · Cited by 93
Yung, D., Kapral, M. K., Asllani, E., Fang, J., & Lee, D. S. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.10.002 · Cited by 93
Procoagulant therapeutics in liver disease: a critique and clinical rationale
Shah, N. L., Intagliata, N. M., Northup, P. G., Argo, C. K., & Caldwell, S. H. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.121 · Cited by 80
Clinical assessment of hemodynamically unstable patients
Sevransky, J. (2009) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32832b70e5 · Cited by 78
Cuker, A. C. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1282-7 · Cited by 77
Self-citationMonitoring and reversal of direct oral anticoagulants
Cuker, A. C., & Siegal, D. M. (2015) · Hematology · doi:10.1182/asheducation-2015.1.117 · Cited by 69
Self-citationThe Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage
Dibu, J. R., Weimer, J. M., Ahrens, C. L., Manno, E. M., & Frontera, J. A. (2015) · Neurocritical Care · doi:10.1007/s12028-015-0213-y · Cited by 64
Effect of rivaroxaban on blood coagulation using the viscoelastic coagulation test ROTEM™
Casutt, M., Konrad, C. J., & Schuepfer, G. (2012) · Der Anaesthesist · doi:10.1007/s00101-012-2091-4 · Cited by 62
Activated prothrombin complex concentrate for dabigatran‐associated bleeding
Schulman, S., Ritchie, B. C., Goy, J., Nahirniak, S., Almutawa, M., & Ghanny, S. (2013) · British Journal of Haematology · doi:10.1111/bjh.12620 · Cited by 56
Characterizing the Severe Reactions of Parenteral Vitamin K1
Britt, R. B., & Brown, J. N. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616674825 · Cited by 56
Red blood cell transfusion: 2016 clinical practice guidelines from AABB
Tobian, A. A. R., Heddle, N. M., Wiegmann, T. L., et al. (2016) · Transfusion · doi:10.1111/trf.13735 · Cited by 56
Batchelor, J. S., & Grayson, A. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000588 · Cited by 50
Delayed intracranial hemorrhage in the anticoagulated patient: A systematic review
Miller, J. S. A., Lieberman, L., Nahab, B., Hurst, G., Gardner-Gray, J. M., Lewandowski, A., Natsui, S., & Watras, J. B. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000725 · Cited by 47
Hernandez, I., Zhang, Y., Brooks, M. M., Chin, P. K. L., & Saba, S. (2016) · Stroke · doi:10.1161/strokeaha.116.015150 · Cited by 45
Oral anticoagulant therapies: Balancing the risks
Nutescu, E. A. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130040 · Cited by 44
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding
Wallvik, N., Eriksson, J., Höijer, J., Bottai, M., Holmström, M., Schulman, S., & Majeed, A. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-07-0498 · Cited by 43
Damluji, A. A., Macon, C. J., Fox, A. L., Garcia, G., Al‐Damluji, M. S., Marzouka, G. R., Myerburg, R. J., Gilchrist, I. C., Cohen, M. G., & Moscucci, M. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.264 · Cited by 19
Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed
Milling, T. J., & Spyropoulos, A. C. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.06.006 · Cited by 10
Pollack, C. V., Eikelboom, J. W., Weitz, J. I., Reilly, P. A., Glund, S., Dubiel, R., Kreuzer, J., Stangier, J., Wang, B., Gagg, J., et al. (2015) · Emergency Medicine Journal · doi:10.1136/emermed-2015-205372.9 · Cited by 9
Self-citation
Cited by
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
Greenberg, S. M., Ziai, W. C., Cordonnier, C., Dowlatshahi, D., Francis, B., Goldstein, J. N., Hemphill, J. C., Johnson, R., Keigher, K. M., Mack, W. J., et al. (2022) · Stroke · doi:10.1161/str.0000000000000407 · Cited by 1,639
Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace · doi:10.1093/europace/euab065 · Cited by 1,132
Metadata
- Authors
- Tomaselli, G. F., Mahaffey, K. W., Cuker, A., Dobesh, P. P., Doherty, J. U., Eikelboom, J. W., Florido, R., Hucker, W., Mehran, R., Messé, S. R., Pollack, C. V., Rodriguez, F., Sarode, R., Siegal, D., & Wiggins, B. S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 70
- Issue
- 24
- Pages
- 3042-3067
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2771562059
- Cited by
- 345
- References
- 90
- FWCI
- 36.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.